Current Report — Form 8-K Filing Table of Contents
Document/ExhibitDescriptionPagesSize 1: 8-K Current Report HTML 34K
2: EX-99 Ex-99.1 Notice of Director Decision to Not Stand HTML 11K
for Re-Election
9: R1 Cover Page HTML 58K
11: XML IDEA XML File -- Filing Summary XML 13K
8: XML XBRL Instance -- mck-20210415_htm XML 38K
10: EXCEL IDEA Workbook of Financial Reports XLSX 6K
4: EX-101.CAL XBRL Calculations -- mck-20210415_cal XML 7K
5: EX-101.DEF XBRL Definitions -- mck-20210415_def XML 44K
6: EX-101.LAB XBRL Labels -- mck-20210415_lab XML 94K
7: EX-101.PRE XBRL Presentations -- mck-20210415_pre XML 44K
3: EX-101.SCH XBRL Schema -- mck-20210415 XSD 15K
12: JSON XBRL Instance as JSON Data -- MetaLinks 15± 21K
13: ZIP XBRL Zipped Folder -- 0000927653-21-000022-xbrl Zip 30K
(Address of Principal Executive Offices, and Zip Code)
(i972)
i446-4800
Registrant’s Telephone Number, Including Area Code
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
i☐
Written
communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
i☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
i☐
Pre-commencement
communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
i☐
Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
iCommon
stock, $0.01 par value
iMCK
iNew York Stock Exchange
i0.625%
Notes due 2021
iMCK21A
iNew York Stock Exchange
i1.500%
Notes due 2025
iMCK25
iNew York Stock Exchange
i1.625%
Notes due 2026
iMCK26
iNew York Stock Exchange
i3.125%
Notes due 2029
iMCK29
iNew York Stock Exchange
Indicate by check mark whether the
registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging growth company i☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a)
of the Exchange Act. ☐
Item 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On April
15, 2021, Dr. N. Anthony Coles informed the Company that he will not stand for re-election at the Company’s 2021 Annual Meeting. Dr. Coles has served as a member of the Board since 2014 and currently serves as a member of the Compensation Committee and the Finance Committee. Dr. Coles will continue to serve as a director and in his committee roles until the 2021 Annual Meeting, to be held on July 23, 2021. The Board expressed its appreciation to Dr. Coles for his service to the Company.
The information contained in this item, including Exhibit 99.1, is furnished to the Commission, but shall not be deemed “filed” with the Commission for purposes of Section 18 of the Securities Exchange Act of 1934 (“Exchange Act”), or incorporated by reference in any filing under the Exchange Act or the Securities Act of 1933, except as expressly stated in any such filing.
Cover Page Interactive Data File - the cover page iXBRL tags are embedded within the Inline XBRL document
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.